(Q41081823)

26 September 2017

title

High-dose intravenous immune globulin therapy for hyperbilirubinemia caused by Rh hemolytic disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1306646

bilirubin metabolic disorder

11 September 2022

main subject

1 reference

J. Rübo

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1306646

11 September 2022

K. Albrecht

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1306646

11 September 2022

P. Lasch

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1306646

11 September 2022

E. Laufkötter

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1306646

11 September 2022

J. Leititis

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1306646

11 September 2022

D. Marsan

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1306646

11 September 2022

B. Niemeyer

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1306646

11 September 2022

J. Roesler

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1306646

11 September 2022

C. Roll

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1306646

11 September 2022

B. Roth

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1306646

11 September 2022

language of work or name

English

0 references

publication date

1 July 1992

1 reference

full work available at URL

26 September 2017

https://api.elsevier.com/content/article/PII:S002234760582551X?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0022-3476(05)82551-X

https://api.elsevier.com/content/article/PII:S002234760582551X?httpAccept=text/plain

29 November 2023

1 reference

https://api.crossref.org/works/10.1016/S0022-3476(05)82551-X

The Journal of Pediatrics

29 November 2023

published in

1 reference

26 September 2017

volume

121

1 reference

26 September 2017

issue

1

1 reference

26 September 2017

page(s)

93-97

1 reference

The Yorkshire antenatal anti-D immunoglobulin trial in primigravidae

26 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2982551-X

Efficacy and long term effects of antenatal prophylaxis with anti-D immunoglobulin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2982551-X

Morbidity and mortality related to exchangetransfusions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2982551-X

ADCC (K-cell) lysis of human erythrocytes sensitized with rhesus alloantibodies. II. Investigation into the mechanism of lysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2982551-X

Intravenous immunoglobulin for neonatal isoimmune thrombocytopenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2982551-X

Intravenous immunoglobulin in treatment of neonatal isoimmune thrombocytopenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2982551-X

High-dose intravenous gammaglobulin in rhesus-haemolytic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2982551-X

Substitutive-inhibitory gamma globulin therapy as prevention of stillbirth in Rh-incompatibility

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2982551-X

Rhesus haemolytic disease treated with high-dose intravenous immunoglobulin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2982551-X

High-dose intravenous immunoglobulin as the sole prenatal treatment for severe Rh immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2982551-X

Intravenous gammaglobulin therapy for prophylaxis of infection in high-risk neonates.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2982551-X

Use of intravenously administered immune globulin to prevent nosocomial sepsis in low birth weight infants: report of a pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2982551-X

Rh isoimmunization during pregnancy: antenatal prophylaxis

7 January 2021

1

1 reference

https://api.crossref.org/works/10.1016/S0022-3476(05)82551-X

Morbidity and mortality associated with exchange transfusion

29 November 2023

4

1 reference

https://api.crossref.org/works/10.1016/S0022-3476(05)82551-X

Neonatal mortality in infants receiving an exchange transfusion

29 November 2023

6

1 reference

https://api.crossref.org/works/10.1016/S0022-3476(05)82551-X

Tolerance of intravenous gamma globulin

29 November 2023

17

1 reference

https://api.crossref.org/works/10.1016/S0022-3476(05)82551-X

29 November 2023

Identifiers

1 reference

26 September 2017

1 reference